ORCHID PHARMA
Back to Income Statement
|
ORCHID PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹811 Cr | ₹709 Cr | ₹582 Cr | ₹505 Cr | ₹399 Cr |
What is the latest Total Expenditure of ORCHID PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹811 Cr |
| Mar2024 | ₹709 Cr |
| Mar2023 | ₹582 Cr |
| Mar2022 | ₹505 Cr |
| Mar2021 | ₹399 Cr |
How is Total Expenditure of ORCHID PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹811 Cr | 14.50 | |
| Mar2024 | ₹709 Cr | 21.83 | |
| Mar2023 | ₹582 Cr | 15.17 | |
| Mar2022 | ₹505 Cr | 26.43 | |
| Mar2021 | ₹399 Cr | - | |
Compare Total Expenditure of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹2,529.4 Cr | -16.8% | -27.5% | -44.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -16.8% |
-27.5% |
-44.7% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses